Homozygous might be hemizygous: CRISPR/Cas9 editing in iPSCs results in detrimental on-target defects that escape standard quality controls

The ability to precisely edit the genome of human induced pluripotent stem cell (iPSC) lines using CRISPR/Cas9 has enabled the development of cellular models that can address genotype to phenotype relationships. While genome editing is becoming an essential tool in iPSC-based disease modeling studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Simkin, Dina, Papakis, Vasileios, Bustos, Bernabe I., Ambrosi, Christina M., Ryan, Steven J., Baru, Valeriya, Williams, Luis A., Dempsey, Graham T., McManus, Owen B., Landers, John E., Lubbe, Steven J., George, Alfred L., Kiskinis, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Resource
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023783/
https://www.ncbi.nlm.nih.gov/pubmed/35276091
http://dx.doi.org/10.1016/j.stemcr.2022.02.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023783/
https://www.ncbi.nlm.nih.gov/pubmed/35276091
http://dx.doi.org/10.1016/j.stemcr.2022.02.008

Ejemplares similares